Target Specificity and Delivery Considerations In Creating RNAi Therapeutics
DOI:
https://doi.org/10.58445/rars.1356Keywords:
RNAi, Therapeutic, Delivery, Target specificityAbstract
RNAi is a naturally occurring process with the ability to destroy foreign RNA. Recently, RNAi is being used to create therapeutics for diseases and foreign viruses. Although it seems rather simple to create a therapeutic through natural processes there are concerns regarding using RNAi as a therapeutic. In this review I address challenges with this form of therapy such as target specificity and delivery. In regards to target specificity I include methods which directly alter the siRNA to increase the specificity of the therapies impact. I also discuss various delivery methods that were used in the past along with methods that are most preferred today. Lastly, I propose a possible model for the therapeutic which combines different specificity and delivery methods.
References
Afrin, Humayra, et al. “Oral delivery of RNAi for cancer therapy.” Springer Link, 27 March 2023, https://link.springer.com/article/10.1007/s10555-023-10099-x. Accessed 23 May 2024.
Becker, Jonas, et al. “Right on target: The next class of efficient, safe, and specific RNAi triggers.” Molecular Therapy, 2022, https://www.cell.com/molecular-therapy-family/nucleic-acids/fulltext/S2162-2531(22)00076-2. Accessed 23 May 2024.
Boudreau, Ryan L., et al. “Rational Design of Therapeutic siRNAs: Minimizing Off-targeting Potential to Improve the Safety of RNAi Therapy for Huntington's Disease.” Molecular Therapy, https://www.cell.com/molecular-therapy-family/molecular-therapy/fulltext/S1525-0016(16)32702-2. Accessed 23 May 2024.
Cisneros, Ethan, et al. “Targeted delivery methods for RNA interference are necessary to obtain a potential functional cure for HIV/AIDS.” Science Direct, 28 June 2023, https://doi.org/10.1016/j.addr.2023.114970. Accessed 17 February 2024.
Lee, Hye-Sook, et al. “Abasic pivot substitution harnesses target specificity of RNA interference.” Nature Communications, 2015, https://www.nature.com/articles/ncomms10154. Accessed 18 12 2023.
Li, Charles X., et al. “Delivery of RNA Interference.” Taylor & Francis Online, vol. 5, no. 18, 2006, p. 7. Taylor & Francis Online, https://www.tandfonline.com/doi/epdf/10.4161/cc.5.18.3192?needAccess=true&role=button.
National Library of Medicine. “RNA Interference (RNAi).” NCBI, 9 November 2017, https://www.ncbi.nlm.nih.gov/probe/docs/techrnai/. Accessed 23 May 2024.
Zhou, Jiehua, et al. “Nanoparticle-Based Delivery of RNAi Therapeutics: Progress and Challenges.” MDPI, 2013, https://www.mdpi.com/1424-8247/6/1/85. Accessed 23 May 2024.
Additional Files
Posted
License
Copyright (c) 2024 Shaila Pochiraju
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license
